Background Itch is common and often debilitating. Itch is best assessed by self-report, often using patient-reported outcome measures (PROMs). Current PROMs for itch are limited and may not capture its full impact on quality of life (QOL). Objective We sought to develop a comprehensive conceptual model of itch to improve the understanding of itch for clinicians and to serve as a framework for development of efficient and valid PROMs of itch. Methods Using mixed methods, including systematic review (n = 491 articles), semi-structured interviews (n = 33 adults with chronic itch with multiple etiologies), and grounded theory using a constant comparative approach, we developed a conceptual model of itch. Results We found the Wilson and Cleary model to be a reasonable framework for organizing our findings. It includes five primary components: biological and physiological variables, symptom status, functional status, general health perceptions, and QOL. We propose a causal relationship beginning with the biological and physiological driving factors, with direct and indirect impacts of itch and its sequelae, including pain and sleep disturbance. These can impair function, lead to task avoidance, stigma, social life and relationship problems, emotional disturbances, and treatment burden. Together, these sequelae alter one's perceptions of health, QOL, and treatment response. Conclusions Our conceptual model demonstrates the profound patient-burden of itch and identifies unmet needs in the evaluation and management of itch.
Introduction
Itch (or pruritus) is a common symptom encountered in dermatology [1] , general internal medicine [2] , and geriatrics [3] . Itch is a reported symptom in approximately 1% of all outpatient visits in the USA [4] and 0.6% of encounters in Australia [5] . Multiple medical disorders are associated with varying degrees of itch, such as primary sclerosing cholangitis and renal failure [6, 7] . Itch is associated with significant impairment of patient-reported quality of life (QOL), physical and mental health, ability to carry out everyday physical activities, difficulties with social activities and relationships, and higher rates of depressed mood and anhedonia [2] .
Itch is a subjective symptom defined as an uncomfortable sensation on the skin that causes a desire to scratch [8] . There are no biomarkers or well-accepted diagnostic tests available to assess the severity of itch. Itch is best assessed using patient-reported outcomes (PROs). Itch is a heterogeneous symptom, analogous to pain, with varying characteristics, such as intensity, quality, frequency, duration, and interference with function [9, 10] . Commonly employed assessments of itch quantify its overall intensity or severity. However, some of these approaches have not been validated, and none capture the full spectrum of itch characteristics or the impact of itch on QOL [10] . There are PRO measures (PROMs) of itch that assess the patient experience, but they can be limited by inadequate evidence of validity, reliability, incomplete representation of the burden of itch, lack of demonstration of cross-cultural validity, length not easily shortened due to scoring requirements, and/or unclear instructions, scoring, and interpretability [10] .
As a first step in developing a valid, comprehensive itch PROM, we sought to create a conceptual model of itch. A conceptual model is a theoretical representation which defines the concepts of interest, their interfaces, and possible determinants [11] . In developing PROMs of itch, it is important that the instruments be (1) relevant and meaningful to patients; (2) conceptually grounded in the many factors at play in the experience of itch; and (3) embedded within a specific conceptual model that indicates the relationship between itch characteristics, disability, and QOL. A previous conceptual model was developed by Verhoeven et al. [12] for itch based on a literature review. However, this model was based on a biopsychosocial model, which has a number of limitations [13] , including emphasis on psychosocial aspects over the complex physiological aspects of itch. Additional frameworks to guide measuring itch have been developed based on expert consensus of international itch experts. These approaches did not include patient involvement or feedback, instead assuming that all important aspects of measuring itch were already known and/or published. However, there remain many knowledge and practice gaps in the assessment and management of itch [14] . In the present study, we used a grounded theory (GT) approach to develop a conceptual model of itch. GT uses the empirical data to generate concepts and theories, rather than starting with existing hypotheses, models, frameworks or potentially biased a priori assumptions [15] . GT employs a systematic approach to generate concepts from the empirical data. We incorporated extensive patient and expert feedback, as well as previous research and knowledge about itch via a systematic review to develop a comprehensive conceptual model of itch that would improve the understanding of itch for clinicians and serve as a framework for efficient and valid PROMs of pruritus.
Methods
This study was approved by the local institutional review board at Northwestern University (Chicago, IL, USA). The conceptual framework was developed utilizing mixed research methods, with an iterative approach to data collection, synthesis, and analysis.
Expert Input
We first identified key concepts closely linked to itch and its treatment. We employed a panel of eight experts to evaluate our concept elicitation process. The panel included two adult dermatologists, a pediatric dermatologist, four measurement experts with qualitative research experience, and one crosscultural expert. The panel addressed contextual questions relating to the burden of atopic dermatitis, and practical questions relating to the structure of the patient interview and design of a semi-structured interview guide intended for in-person interviews, including review of interview questions and probes to enhance relevance and fit to the clinical setting of chronic itch. In October 2014, experts participated in up to ten face-to-face and/or telephone meetings to contribute to the development of the interview guide. The expert panel discussed and refined the draft patient interview guide, and consensus was achieved by discussion. For each of the key concepts and structure of the interview guide, consensus was considered achieved if seven of eight on the panel were in agreement.
Semi-Structured Patient Interviews
To refine and focus the concepts identified by our expert panel, and explore additional concepts relevant to patients, we conducted individual semi-structured interviews (interview guide presented in the Electronic Supplementary Material) with adults (≥ 18 years) suffering from chronic itch across multiple etiologies (Table 1) . Based on the principles of GT, there was no a priori hypothesis, and sample size is best determined by saturation (i.e., when no new relevant concepts are elicited) rather than a formal power analysis. Sample size consideration was based on previous research suggesting that 6-12 interviews are typically required for theoretical saturation [16] [17] [18] . We worked within that range in selection of eight experts, but chose to oversample patients (n = 33) for semi-structured interviews to ensure adequate representation of the range of etiologies and severities of pruritic dermatologic disorders, as well as uremic pruritus, generalized idiopathic pruritus, and rheumatologic disease. Patients with chronic itch were identified and recruited by medical team members from dermatology, rheumatology, nephrology, and oncology within a large Midwestern teaching hospital system.
Two experienced interviewers conducted face-to-face individual interviews, which were audio recorded. Audio recording of interviews were transcribed verbatim, excluding identifying information, and were analyzed by three coders.
The coding team convened to generate a mutually agreeable list of themes that were expressed by interviewees or reflected in currently available literature and to optimize coding. In addition, the expert panel convened after the first five transcripts were coded and initial development of the codebook to further refine coding and finalize the codebook.
Using selective coding, constant comparative methodology [19, 20] , and information from the extant literature identified in the systematic review (Sect. 2.3), the coders identified common themes, created definitions, and developed coding rules regarding specific patient comments. After developing coding rules, thematic analysis was performed in NVivo 10 (QSR International, Burlington, MA, USA) with an overall final concordance of coding concepts between coders of > 99%.
The majority of participants were female (69.7%); most had white race/ethnicity (66.7% white, 15.2% black, 12.1% Asian, and 6.1% Hispanic). Ages ranged from 22 to 74 years (mean 53.7 years) and the highest educational attainment included high school (45.4%), college (39.4%), and advanced degree (15.2%).
Systematic Review
Once the key concepts were identified by the expert panel, we conducted a systematic literature review concurrently with the qualitative research. The goals of the systematic review were to identify and examine existing concepts related to presentation and burden of itch, and the results previously described [21] . MEDLINE, EMBASE, and the Cochrane Library were searched from start to 1 February 2015 for a combination of 'prurit*'/'itch*' (* = wildcard character) and 'quality of life'/'QOL'/'patient burden'/'patient reported outcome'/'patient report'/'patient perspective'/'patient centered'. Studies were excluded based on the title and/ or abstract if there was no indication they investigated or discussed pruritus and/or its impact on QOL. Therapeutic trials, animal studies, and foreign language articles were excluded. Two reviewers (PD and RK) performed the title/abstract review and data extraction, and differences were resolved by discussion.
Thematic Analysis and Saturation
Patient interview transcripts and results of the systematic review were coded and thematic analysis was performed by at least two coders using NVivo 10, with resolution of disagreements by discussion and consensus. Using constant comparative logic, coding categories were continually refined by collapsing redundant categories and removing irrelevant categories. Saturation-the extent to which no new relevant information was obtained-was assessed beginning with the twelfth interview. Data saturation was captured using a saturation grid, as judged by replication and redundancy [16] of themes and sub-themes. Saturation was achieved when three consecutive interviews occurred without producing a new, relevant concept. 
Thematic Review
Themes identified in the open-ended interviews and systematic review were reviewed by the expert panel. The panel reviewed and further organized the themes into meaningful units. These were further grouped into broader concepts, which became the foundation of the itch-specific conceptual model. The panel also reviewed the concepts for their relevance and fit to the clinical setting of chronic itch. A Microsoft Excel ® (Microsoft, Tacoma, WA, USA) database was created for concept review, which yielded 12 final conceptual categories.
Drafting an Itch-Specific Conceptual Model
To organize our findings, we used the basic framework proposed by Wilson and Cleary [22] for the itch-specific conceptual model. It includes five primary components: biological and physiological variables, symptom status, functional status, general health perceptions, and health-related QOL (HR-QOL). This model was a useful foundation for our itch-specific model because it encompassed all of the domains reflected in our qualitative findings. We modified the model to include considerations specific to chronic itch, based on the qualitative findings for patients with chronic itch, in addition to the expert panel, and systematic literature review findings.
Results

Expert Panel
Eight distinct concepts were identified and agreed upon by our expert panel: (a) how patients describe their itch; (b) general impact of itch on QOL; (c) emotional impacts of itch; (d) social impacts of itch; (e) functional limitations; (f) impact on sleep; (g) adverse effects of treatments for itch; and (h) any concerns regarding treatment for itch.
Patient Interviews
We conducted semi-structured interviews with 33 adults suffering from chronic itch across multiple etiologies (Table 1) . We hypothesized there are differences in the characteristics and QOL impact associated with different etiologies of itch. Therefore, we interviewed patients with a range of etiologies to ensure comprehensive capture of itch experiences and concepts. Saturation was achieved at 31 interviews. Patient descriptions of itch are detailed in Sect. 3.6.
Systematic Review
The systematic literature search yielded 1889 articles, of which 491 contained at least one concept related to itch, including 24 original research studies and multiple prior models and frameworks of itch. A full list of relevant articles is available in the Electronic Supplementary Material Results section. Original articles and review articles produced 366 and 1669 distinct nested concepts, respectively.
We identified ten general concepts, most with multiple nested concepts: emotional effects (23 nested concepts), functional limitations (ten nested concepts), relationship-social effects, sleep impairment, physical manifestations of itch (15 nested concepts), exacerbating factors (ten nested concepts), self-consciousness and embarrassment, temporal aspects (11 nested concepts), treatment-related concerns (eight nested concepts), and other miscellaneous concerns related to itch. After completion of coding all interview transcripts and manuscripts from the systematic review, themes identified were reviewed and further organized by the expert panel.
Itch-Specific Conceptual Model
The expert input, patient interviews, and literature review informed development of the conceptual model. Our itchspecific conceptual model is modified from the model proposed by Wilson and Cleary [22] and hypothesizes a causal relationship beginning with biological and physiological variables, with direct and indirect impacts of itch and its sequelae, including pain and sleep disturbance. These in turn impair function, lead to task avoidance, stigma, social life and relationship impacts, emotional disturbances, and treatment burden. All of these may directly and/or indirectly impact one's perceptions of health, HR-QOL, and treatment response (Fig. 1 ). The conceptual model is described in detail in Sects. 3.5-3.14.
Biological and Physiological Variables
The 'biological and physiological variables' component of the model includes the various etiologies and triggers of chronic itch, including inflammatory skin disease (e.g., atopic dermatitis, psoriasis), systemic disease (e.g., liver and renal disorders), neurological disorders (e.g., brachioradial pruritus), medication-induced itch (e.g., opioids and adverse events with other medications), itch associated with burns, and idiopathic itch. Many different peripheral and central mechanisms of itch have been implicated across various etiologies [23] . There is a complex interplay of these mechanisms that predisposes to itch and increases susceptibility to exogenous stimuli. These etiologies are relevant in the clinical evaluation and management of patients with chronic itch. However, the mechanisms underlying itch in these disorders are not well-understood. Therefore, this component of the conceptual model was not a major focus of this work.
Symptom Status
Multiple Dimensions of Itch
The 'symptom status' component of the model includes the patient experience of itch. The symptom 'itch' is characterized by an urge to scratch. Like pain, its experience and effects can be quite varied. Intensity of itch was a primary concern. Patients were also concerned by itch characteristics. Prolonged duration and persistence of the itch were particularly concerning: patients described it as "relentless", "I am afraid that I am going to deal with this for a long time", "I don't want it to affect me 24/7", "it just doesn't stop itching", and "I'm concerned that things are going to get worse before it gets better, this is my concern all the time". Unpredictable flares and recurrences were also a major concern, as described by quotes such as "I am just so upset that this has come back" and "you never know when it's going to hit you". Body site of itch was also important, as itch of the genitals and axillae were especially embarrassing to scratch, and itch on the hands and feet led to more functional limitations.
Various combinations of these dimensions of itch had different sequelae. For example, one patient revealed that persistent, moderate-intensity generalized itch had a more harmful impact than a short-lived, intense localized itch: "I used to be able to deal with the really bad itch when it happened some of the time, but now I got a low-grade itch all day and all night and I can't do anything." Another patient reported that "it pretty much just affected everything every day because it didn't matter what time, at some point throughout the day I had to scratch because I was itchy."
Itch Quality and Pain
Our qualitative analyses and systematic review revealed that there are different qualities of itch. Twenty-seven of 33 subjects described their itch with additional descriptors (Table 2 ). Multiple patients endorsed that their itch was not superficial. For example, it "felt like the itch came from the inside" and "it goes further than just skin deep, it is not just like on the surface."
Our qualitative analyses revealed that many patients with chronic itch also experienced pain. For some, the pain only occurred after traumatizing the skin with scratching, rubbing, and/or picking the skin in order to alleviate the itch. For others, the pain occurred concomitantly with the itch, even if they did not manipulate the skin (Table 3) .
Some patients with chronic itch may have associated hyperknesis (prolonged and stronger itch to punctate mechanical stimulus) and alloknesis (itch evoked by light touch that is not typically pruritic). This latter symptom may particularly predispose patients to worsening of itch from exogenous and mechanical stimuli in contact with the skin. Patients in our sample reported multiple stimuli that worsened their itch (Table 2 ).
Scratching
Our qualitative research found that the scratching per se was problematic in all 33 subjects. That is, substantial numbers of patients reported having to stop everything to scratch (n = 8) and being unable to stop scratching (n = 9), which was embarrassing (n = 16) and had direct effects on functional status and HR-QOL (n = 7). In some patients, concerns related to scratching were even greater than the effects of the itch per se. Of note, while patients reported that scratching provided short-term relief of itch, chronic scratching and rubbing of the skin has been shown to cause a vicious itch-scratch cycle and increase itch long-term [24] . The arrows in the proposed conceptual model depict these relationships (Fig. 2). 
Sleep Disturbance
The itch, pain, and uncontrollable scratching contribute to sleep disturbance, including inability to fall asleep or stay asleep, frequent and prolonged night-time awakenings, restless sleep, and difficulty getting up in the morning. These were accompanied by increased daytime fatigue and functional impairment.
Functional Status
Functional status includes the myriad effects of chronic itch on physical activities, function, and task avoidance. Task avoidance refers to ceasing engagement in certain activities to manage itch onset or worsening. The capacity to tolerate discomfort and personal motivation for a given activity varies across individuals and will accordingly influence one's rating of functional capability or limitation. If one's tolerance threshold is exceeded, he/she may report avoiding activities because of itch.
Our qualitative research found a complex relationship between itch, functional disturbances, and task avoidance. Patients reported avoidance of many different tasks that can exacerbate the itch, including physical activity ranging from light to vigorous intensity (n = 12), spending time outdoors in warmer weather (n = 12), turning on the heat when indoors (n = 3), going on vacation (n = 3), reading a book (n = 6), watching television (n = 2), driving (n = 2), or other tasks requiring prolonged concentration (n = 21), and wearing certain types of clothing (wool or harsh materials, tight fitting, revealing of scratches, occlusive shoes, etc.) (n = 16).
For example, many patients reported limiting exercise and other forms of moderate and vigorous physical activity in order to minimize excessive heat and sweating (n = 8), which are common triggers of itch [25, 26] . Patients' clothing choices were impacted in three different ways. First, they avoid clothing that is tight fitting or made of wool or occlusive footwear that can trigger the underlying itch. Second, some patients reported embarrassment from wearing clothing or footwear that reveals the physical manifestations of their scratching the skin, e.g., erosions or prurigo nodules. Third, oozing and bleeding secondary to erosions from intense scratching ruined clothing and linens.
Difficulty concentrating secondary to itch, fatigue, sleep disturbance, and adverse effects from sedating anti-itch treatments all contribute to difficulty performing activities of daily living, including difficulty driving a car, shopping, dealing with finances, and even performing simple tasks. These limitations impact patients with itch in all settings. Patients in our sample commonly described impacts in the home, school, and work settings.
Stigma
The 'stigma' component includes the impact of stigmatization related to itch, scratching behavior, and the physical manifestations of itch. Our qualitative research revealed that many patients had friends, family members, co-workers, and other persons that did not understand them and perceived them as being sick, contagious, dirty, neurotic, crazy, abnormal, etc. For example, some patients described "to be always scratching, you know … people look at you like you have some type of disease or something that is contagious" and "I didn't want to have anyone judge me because people are 
Social Life and Relationships
Many patients reported embarrassment (n = 19), self-consciousness (n = 29), and stigma (n = 4) secondary to scratching behavior and its physical sequelae. That is, patients found the urge to scratch to be so intense that they could not avoid scratching even in a public setting. This then leads to embarrassment when others see them scratching. Patients were frustrated by others, including friends and family, telling them to stop scratching. In addition, patients were embarrassed by the visually apparent physical signs of scratching. Patients had anxiety over the unpredictability of their itch and whether they may develop intense itching during social interactions. Together, all of these concerns led to profound emotional disturbances, a sense of social isolation, avoidance of and strained social interactions with friends, family and co-workers, and avoidance of travel and vacations.
Emotional Disturbances
Almost all patients reported some degree of emotional disturbance (n = 30), including sadness, depression, anxiety, agitation, despair, guilt, hopelessness, fear, and panic. Most patients with emotional disturbances reported that these correlated directly with the severity of itch. That is, severe itch (e.g., high intensity, extensive, persistent) was associated with more profound emotional disturbances than milder itch. These emotional disturbances were reported to almost entirely disappear when the itch was well-controlled. For example, "when your skin is broken out and itchy and you're feeling kind of down and then you put the creams on and everything starts to improve, your mood improves along with that."
Treatment-Related Concerns
Our qualitative research identified a substantial burden from treating their itch and other treatment-related concerns. These included stinging and burning from application of topical treatments (n = 3), sedation, and multiple other adverse events (e.g., dry mouth, dizziness, gastrointestinal discomfort, headaches, etc.) from oral anti-itch treatments (n = 4). Patients were bothered by the inconvenience, lack of feasibility, and large amount of time devoted to their skincare regimen (n = 12). In addition, patients reported that the greasiness of topical treatments ruined their clothing, pajamas, and linens, and was often highly visible and unsightly (n = 5). Morning application of topical anti-pruritics, emollients, or treatments of the underlying etiology of itch was associated with difficulties getting to school and/or work on time (n = 3).
Most patients reported frustration regarding the lack of anti-itch treatments that are immediately effective at reducing itch (n = 24). Scratching and rubbing of itchy skin was the most commonly used method for short-term relief of itch. However, some patients reported that the itch was "internal" and that scratching was therefore not effective. Some patients found that local application of ice packs, cold water compresses, and/or other cold items within reach was effective at reducing their itch. Beyond these simple approaches, most patients reported that currently available over-the-counter and prescription anti-pruritics were ineffective.
Patients were frustrated by the lack of long-term efficacy of their anti-itch treatments (n = 4). For example, patients considered oral corticosteroids to be a "temporary fix" and "it comes back with a vengeance" after discontinuation. Patients considered that the most effective approach for long-term control of itch was to successfully treat the underlying disorder where possible (n = 10). However, they were frustrated by the lack of consistently effective treatments targeting the symptom of itch, particularly while awaiting improvement of the underlying etiology of itch and when they had chronic refractory disease.
Characteristics of the Individual
The 'characteristics of the individual' component includes emotional response to itch, baseline vitality, and personal preferences for task exertion. Our qualitative research indicated that these characteristics influence the perception of itch, impact on social life, relationships and functional limitation, task avoidance, emotional disturbances, treatment-related concerns, and ultimately general health perception and/or QOL. We hypothesized that individual characteristics and differences play an important role in the conceptual model.
In particular, individual differences in motivation were found to influence functional limitation and task avoidance. These differences also influenced patients' emotional reactions to itch, including anxiety and depression. The baseline activity motivation includes whether a person has a preference toward particular activities, such as going to the gym, clothing decisions, and occupational tasks. For example, we hypothesize that patients who are more sedentary may not be as bothered by their inability to participate in vigorous physical activities. Further, patients with better coping skills and social support may not have as much of a negative impact from itch on their relationships and social life, and may have fewer emotional disturbances.
Characteristics of the Environment
The 'characteristics of the environment' component includes influences of climate, irritants, stress, and occupational exposures on itch. Environmental factors often trigger itch and can have a direct effect on itch experience and sequelae. Extreme low or high humidity, excess heat, exposure to allergens, irritants and pruritogens from personal care products, home and occupational environment, and/or psychosocial stressors were described in terms of their impact on itch characteristics, functional limitations, emotional disturbances, task avoidance, treatment burden, and ultimately treatment response and overall QOL.
Outcomes
'General health perceptions', 'quality of life', and 'treatment response' were the final outcomes of our conceptual model. These concepts were ultimately driven by all of the intermediate steps. General health perceptions that emerged from our qualitative findings included feelings of worry regarding itch as a symptom of worsening or uncontrolled medical disease and as a sign of poor overall health.
Discussion
Our conceptual model of itch, guided by the Wilson and Cleary framework, was supported by extensive qualitative input from patients and experts, as well as the scientific literature. The model organizes our understanding of patientburden and the QOL impact of itch. Further, the information we gathered identifies multiple unmet needs in the evaluation and management of itch, including proper assessment of itch characteristics and triggers, and QOL impairment secondary to itch.
Our qualitative findings revealed that multiple characteristics of itch were important to patients, including intensity, frequency, duration, persistence, site, quality, and related sensitivity to external stimuli. These characteristics affected other aspects of the model. The multiple descriptors of itch identified in semi-structured interviews are consistent with previous reports [27, 28] . Moreover, an important component of the patient-burden of itch stems from concomitant physical and mental health symptoms that are highly correlated with itch severity, including pain, sleep, and emotional disturbances. These related symptoms should routinely be assessed in clinical practice and therapeutic trials for itch, though currently may not be adequately assessed.
Our findings revealed there are myriad endogenous and exogenous exacerbating influences on itch. However, most patients reported only being affected by a small number of triggers, i.e., not all possible triggers are relevant in all patients. It is essential that a patient-centered approach be taken for the evaluation of itch triggers in order to develop customized and optimized educational strategies to mitigate itch.
Our conceptual model highlights the extensive patientburden of itch, including functional limitations, task avoidance, social and relationship effects, emotional disturbances, and treatment-related concerns. Some concepts elicited in our qualitative analysis have not been elucidated or previously captured in existing PROMs. These results highlight the need for a more comprehensive PROM of itch.
This study has a number of strengths, including use of a GT approach that incorporated extensive input from patients and experts and myriad concepts elicited from a comprehensive literature review, including previous qualitative research studies, existing pruritus assessments, and multiple models and frameworks of itch. There were still multiple new empirical concepts elicited from the semi-structured interviews. The semi-structured interviews included subjects with a broad representation of age, race/ethnicity, sex, and educational level. However, there are some potential limitations. All patients in the semi-structured patient interviews were recruited from a single quaternary care center, though patients resided in four different Midwestern states. The sample size of the concept elicitation interviews was consistent with previous qualitative research [17, 18] , and we achieved saturation at interview 31. Nevertheless, larger studies are underway to determine whether novel concepts in our model of itch are generalizable to all patients with itch. However, we conducted a systematic review of the literature to reflect the extensive research of itch previously performed. Thus, our conceptual model is both comprehensive and generalizable to the broader itch population.
Conclusions
There are currently no biomarkers or diagnostic tests for assessing itch severity. Given the subjective and multidimensional nature of itch, a patient-centered approach is essential to evaluating the symptom-burden and treatmentrelated concerns. The qualitative input from patients and experts fits well into a new itch-specific conceptual model, which lends itself to future applications in the design of a conceptual framework and PROM. This model represents the relationship between itch and potential critical clinical trial components, such as different etiologies of itch, concomitant pain, sleep and emotional disturbance, functional limitations, stigma, social and relationship effects, and general health perceptions and overall QOL. Our next step is to develop novel instruments, using the PROMIS (PatientReported Outcomes Measurement Information System) methodology [29] , to measure the PRO components of the conceptual model, including the development and testing of large pools (item banks) of questions to measure the characteristics, triggers, and QOL impairment secondary to itch, which could be incorporated in clinical trials and practice.
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